+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Middle East and Africa Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; End User; and Country- Product Image
Middle East and Africa Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; End User; and Country- Product Image
Sale

Middle East and Africa Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; End User; and Country

  • PDF Icon

    Report

  • 164 Pages
  • November 2020
  • Region: Africa, Middle East
  • The Insight Partners
  • ID: 5231477
UP TO OFF until Jun 30th 2024
Description Jump to:
According to a new market research study of ‘Middle East & Africa Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Analysis by product, and end-user’ the Middle East & Africa kidney disease market is expected to reach US$ 7,406.2 s 2019. The market is estimated to grow with a CAGR of 5.5% from 2020-2027. The report provides trends prevailing in the Middle East & Africa kidney disease market and the factors driving market along with those that act as hindrances.

Based on the end-user, the Middle East & Africa the kidney disease market, is segmented into hospital, diagnostic laboratories, and others. The hospital segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period. Hospitals are the primary healthcare centers where the kidney diseases are extensively treated. These facility centers provide advantages presence of integrated healthcare facilities, the availability of technologically advanced infrastructures, and the ability to perform complex procedures. In addition, the availability of favorable reimbursement policies influences the increasing number of kidney disease treatment procedures. Moreover, the faster development of healthcare infrastructure facilities and a surge in healthcare spending in developing regions is expected to drive the hospitals segment’s growth over the forecast period.

The growth of this market is estimated to grow owing to key driving factors such as rising prevalence of diabetes resulting in renal diseases and rising incidences of renal diseases. However, the market is expected experiencing slow growth during the forecast period owing to the constraint of finance and resources in developing countries.

Pfizer Inc., Teva Pharmaceutical Industries Ltd, Amgen Inc. are among the leading companies operating in the Middle East & Africa kidney disease market.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africakidney disease market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in theMiddle East & Africa kidney disease market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth, offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Kidney Disease Market - by Product
1.3.2 Kidney Disease Market - by End User
1.3.3 Middle East & AfricaKidney Disease - by Country
2. Middle East & Africa Kidney Disease - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Kidney Disease - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Kidney Disease Market- Middle East & Africa PEST Analysis
4.3 Expert Opinion
5. Middle East & Africa Kidney Disease - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Diabetes Resulting inRenal Diseases
5.1.2 Rising Incidences of Renal Diseases
5.2 Market Restraints
5.2.1 The constraint of Finance and Resources in Developing Countries
5.3 Market Opportunities
5.3.1 Increasing Prevalence of Obesity across the Region
5.4 Future Trends
5.4.1 Better Government Initiatives for Kidney Disease Market
5.5 Impact Analysis
6. Kidney Disease Market - Middle East & Africa Analysis
6.1 Middle East & AfricaKidney Disease Revenue Forecasts and Analysis
7. Middle East & Africa Kidney Disease Analysis and Forecasts to 2027 - by Product
7.1 Overview
7.2 Kidney Disease Market Revenue Share, by Product (2019 and 2027)
7.3 Diagnosis
7.3.1 Overview
7.3.2 Diagnosis: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.3.3 Blood Tests
7.3.3.1 Overview
7.3.3.2 Blood Tests: Kidney Disease Market - Revenue and Forecast to 2027(US$ Million)
7.3.4 Urine Tests
7.3.4.1 Overview
7.3.4.2 Urine Tests: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.3.5 Imaging Tests
7.3.5.1 Overview
7.3.5.2 Imaging Tests: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.3.6 Others
7.3.6.1 Overview
7.3.6.2 Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Treatment
7.4.1 Overview
7.4.2 Treatment: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3 Drug Class
7.4.3.1 Overview
7.4.3.2 Drug Class: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.1 ACE Inhibitors
7.4.3.2.1.1 Overview
7.4.3.2.1.2 ACE Inhibitors: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.2 Angiotensin-II Receptor Blockers
7.4.3.2.2.1 Overview
7.4.3.2.2.2 Angiotensin-II Receptor Blockers: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.3 Diuretics
7.4.3.2.3.1 Overview
7.4.3.2.3.2 Diuretics: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.4 Others
7.4.3.2.4.1 Overview
7.4.3.2.4.2 Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.4 Dialysis
7.4.4.1 Overview
7.4.4.2 Dialysis: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.5 Others
7.4.5.1 Overview
7.4.5.2 Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
8. Middle East & AfricaKidney Disease Analysis - by End-User
8.1 Overview
8.2 Kidney Disease Market Revenue Share, by End User (2019 and 2027)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Diagnostic Laboratories
8.4.1 Overview
8.4.2 Diagnostic Laboratories: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
9. Kidney Disease Market Revenue and Forecasts to 2027 - Geographical Analysis
9.1 Middle East & Africa: Kidney Disease Market
9.1.1 Overview
9.1.2 Middle East & Africa: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
9.1.3 Middle East and Africa: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.1.3.1 Middle East and Africa: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.3.2 Middle East and Africa: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.3.2.1 Middle East and Africa: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.4 Middle East and Africa: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.5 Middle East & Africa: Kidney Disease Market, by Country, 2019& 2027 (%)
9.1.6 Saudi Arabia: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 Saudi Arabia: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.2 Saudi Arabia: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.1.6.2.1 Saudi Arabia: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.6.2.2 Saudi Arabia: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.6.2.2.1 Saudi Arabia: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.6.3 Saudi Arabia: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.7 UAE: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 UAE: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 UAE: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.1.7.2.1 UAE: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2 UAE: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2.1 UAE: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.7.3 UAE: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.8 South Africa: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 South Africa: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 South Africa: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.1.8.2.1 South Africa: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.8.2.2 South Africa: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.8.2.2.1 South Africa: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.8.3 South Africa: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
10. Impact Of COVID-19 Pandemic on Middle East & AfricaKidney Disease
10.1 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11. COMPANY PROFILES
11.1 Pfizer Inc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Teva Pharmaceutical Industries Ltd
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 GlaxoSmithKline plc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Amgen Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Sysmex Corporation
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Fresenius SE & Co. KGaA
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Siemens AG
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About the Publisher
12.2 Glossary of terms
List of Tables
Table 1. Middle East and Africa: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 2. Middle East and Africa: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
Table 3. Middle East and Africa: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
Table 4. Middle East and Africa: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 5. Middle East and Africa: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 6. Saudi Arabia: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 7. Saudi Arabia: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
Table 8. Saudi Arabia: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
Table 9. Saudi Arabia: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 10. Saudi Arabia: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 11. UAE: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 12. UAE: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
Table 13. UAE: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
Table 14. UAE: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 15. UAE: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 16. South Africa: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 17. South Africa: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
Table 18. South Africa: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
Table 19. South Africa: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 20. South Africa: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 21. Glossary of Terms,Kidney disease
List of Figures
Figure 1. Kidney Disease Segmentation
Figure 2. Middle East & Africa Kidney Disease Overview
Figure 3. Diagnosis Segment Held Largest Share of Product in Kidney Disease Market
Figure 4. Saudi Arabia is Expected to show Remarkable Growth during the Forecast Period
Figure 5. Kidney Disease Market - Middle East & Africa PEST Analysis
Figure 6. Kidney Disease Market Impact Analysis of Driver and Restraints
Figure 7. Middle East & Africa Kidney Disease - Revenue Forecasts and Analysis-2019-2027
Figure 8. Kidney Disease Market Revenue Share, by Product (2019 and 2027)
Figure 9. Diagnosis: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 10. Blood Tests: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 11. Urine Tests: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 12. Imaging Tests: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Treatment: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Drug Class: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. ACE Inhibitors: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Angiotensin-II Receptor Blockers: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 18. Diuretics: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Dialysis: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Kidney Disease Market Revenue Share, by End User (2019 and 2027)
Figure 23. Hospitals: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Diagnostic Laboratories: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Middle East & Africa: Kidney Disease Market, by Key Country - Revenue (2019) (USD Million)
Figure 27. Middle East & Africa Kidney Disease Market Revenue and Forecast to 2027 (USD Million)
Figure 28. Middle East & Africa: Kidney Disease Market, by Country, 2019& 2027 (%)
Figure 29. Saudi Arabia: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
Figure 30. UAE: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
Figure 31. South Africa: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in Middle East & Africaon Country Markets

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott
  • F. Hoffmann-La Roche Ltd
  • AbbVieInc
  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc
  • Sysmex Corporation
  • Siemens AG
  • Amgen Inc

Related Topics

Related Reports

Global Polycystic Kidney Disease Drugs Market by Type (ADPKD, ARPKD), Treatment (Medication, Surgery), Diagnosis, Distribution Channels, End-User - Forecast 2024-2030 - Product Image

Global Polycystic Kidney Disease Drugs Market by Type (ADPKD, ARPKD), Treatment (Medication, Surgery), Diagnosis, Distribution Channels, End-User - Forecast 2024-2030

  • Report
  • 199 Pages
  • Global
From
Rare Kidney Diseases Global Market Report 2024 - Product Image

Rare Kidney Diseases Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Kidney Disease Global Market Report 2024 - Product Image

Kidney Disease Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Chronic Kidney Disease Market Analysis & Forecast 2024-2034: Market By Product (Diagnosis, Treatment; By Route of Administration; By End-user; and By Region - Product Image

Global Chronic Kidney Disease Market Analysis & Forecast 2024-2034: Market By Product (Diagnosis, Treatment; By Route of Administration; By End-user; and By Region

  • Report
  • 145 Pages
  • Global
From
Chronic kidney disease treatment Market By Treatment, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Image

Chronic kidney disease treatment Market By Treatment, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • 238 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.